The PI3K/AKT/mTOR signaling pathway, which is a central regulator of cell survival and proliferation, is constitutively active in RCC and reportedly implicated in RCC pathogenesis and progression. The gene discussed is PIK3CD; the disease is renal cell carcinoma.